FDA Approves Monoclonal Antibody To Treat COVID-19 For First Time


Authored by Mimi Nguyen Ly via The Epoch Times (emphasis ours),

The logo of Swiss pharmaceutical giant Roche in Basel on Feb. 2, 2011. (Fabrice Coffrini/AFP/Getty Images)

The U.S. Food and Drug Administration (FDA) has, for the first time, approved a monoclonal antibody to treat COVID-19 in hospitalized patients.

Healthcare company Roche’s Actemra (tocilizumab) intravenous (IV) was approved by the FDA to treat severe COVID-19 in adults, the company announced on Wednesday.

Specifically, the drug is approved in cases where the patient is hospitalized and is receiving systemic corticosteroids, as well as requiring supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation.

It is the first FDA-approved monoclonal antibody to treat COVID-19, the company stated.

Monoclonal antibodies are laboratory-created proteins that mimic natural antibodies the body produces to fight off harmful pathogens, such as the SARS-CoV-2 virus that causes COVID-19.

Actemra does not directly target SARS-CoV-2 but addresses the inflammation that occurs from COVID-19 infection. The monoclonal antibody reduces inflammation by blocking the interleukin-6 receptor.

The drug is recommended to be administered as a single 60-minute IV infusion.

According to Roche, more than one million hospitalized COVID-19 patients have been treated with Actemra worldwide since the start of the pandemic.

The drug was previously FDA-authorized for emergency use in hospitalized adults and pediatric COVID-19 patients (above 2 years of age) back in June 2021.

Right now, the FDA has not approved Actemra to treat hospitalized patients aged 2 to under 18, but the Emergency Use Authorization (EUA) still applies.

Actemra is not authorized or approved for the treatment of outpatients with COVID-19.

According to Roche, Actemra is approved for use in more than 30 countries for patients hospitalized with severe COVID-19. This includes the European Union, Japan, the United Kingdom, New Zealand, Russia, and Brazil. It is also provisionally approved in Australia, and authorized for emergency use in Ghana, Mexico, and Korea for certain patients hospitalized with severe or critical COVID-19.

The drug has also been recommended and prequalified by the World Health Organization (WHO).

In the United States, Actemra is the seventh FDA-approved indication since it was launched in 2010. It has been approved for use against other inflammatory diseases, including rheumatoid arthritis.


In Case You Missed It:

Scientists Develop Gelatinous Robots To Crawl Through Human Body To Deliver Medical Payloads, Diagnose Illnesses

COWARD: Sean Hannity Turns on Trump and The American People, Backs Election Thieves in Court

For breaking news from one of the most over the target and censored names in the world join our 100% Free newsletter at Newsletter, The best way to get the information you want.

Also follow us at Gab

Follow us on Gab.com , Like, comment, and subscribe.

Telegram, Join our Telegram chat

Shop Patriot and Detox the Deep State by shopping with our sponsors.

Protect your future with ITM Trading, If you haven’t prepared for the collapse, you're out of time... BUY GOLD and SILVER NOW!

RedPillLiving.com, Home of Sleepy Joe – the world’s most powerful all natural sleep formula and The Great Awakening Gourmet Coffee for Patriots.

TheGreatAwakeningCoffee.com, Gourmet Coffee for Patriots!

The Serapeum.com, The Hidden History of Man & The Mystery Babylon Religion of The Deep State.

This post was originally published on this site